Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis

Anticancer Research

Volumn 30, Issue 6, 2010, Pages 2393-2397

  Szkandera, Joanna ^a   Knechtel, Gudrun ^a   Stotz, Michael ^a   Hofmann, Günter ^a   Langsenlehner, Uwe ^b   Krippl, Peter ^c   Langsenlehner, Tanja ^a   Dehchamani, Dadbeh ^a   Samonigg, Hellmut ^a   Renner, Wilfried ^a   Gerger, Armin ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Internal Outpatient Department   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Colorectal cancer; HIF1A1; Polymorphisms; Prognosis

Indexed keywords

DNA; FLUOROURACIL; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; COLORECTAL CANCER; DISEASE FREE SURVIVAL; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENOTYPE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 77955068657     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55(2): 74-108, 2005.
2. Center MM, Jemal A and Ward E: International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 18(6): 1688-1694, 2009.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59(4): 225-249, 2009.
4. Rannala B: Finding genes influencing susceptibility to complex diseases in the post-genome era. Am J Pharmacogenomics 1(3): 203-221, 2001.
5. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3(10): 721-732, 2003.
6. Vaupel P: The role of hypoxia-induced factors in tumor progression. Oncologist 9(5): 10-17, 2004. (Pubitemid 39658341)
7. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM and Johnson RS: Hypoxia-inducible factor-lalpha is a positive factor in solid tumor growth. Cancer Res 60(15): 4010-4015, 2000. (Pubitemid 30636574)
8. Pouysségur J, Dayan F and Mazure NM: Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441(7092): 437-443, 2006.
9. Wang GL and Semenza GL: Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270(3): 1230-7, 1995.
10. 2 tension. Proc Natl Acad Sci USA 92(12): 5510-5514, 1995.
11. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15: 551-578, 1999.
12. Semenza GL, Rue EA, Iyer NV, Pang MG and Kearns WG: Assignment of the hypoxia-inducible factor 1alpha gene to a region of conserved synteny on mouse chromosome 12 and human chromosome 14q. Genomics 34(3): 437-439, 1996.
13. 2-regulated prolyl hydroxylation. Science 292(5516): 468-472, 2001.
14. Masson N, Willam C, Maxwell PH, Pugh CW and Ratcliffe PJ: Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J 20(18): 5197-5206, 2001.
15. Salceda S and Caro J: Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272(36): 22642-7, 1997.
16. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER and Ratcliffe PJ: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399(6733): 271-275, 1999.
17. Tanimoto K, Makino Y, Pereira T and Poellinger L: Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J 19(16): 4298-4309, 2000.
18. Dang CV and Semenza GL: Oncogenic alterations of metabolism. Trends Biochem Sci 24(2): 68-72, 1999.
19. Clifford SC, Astuti D, Hooper L, Maxwell PH, Ratcliffe PJ and Maher ER: The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. Oncogene 20(36): 5067-5074, 2001.
20. Tanimoto K, Yoshiga K, Eguchi H, Kaneyasu M, Ukon K, Kumazaki T, Oue N, Yasui W, Imai K, Nakachi K, Poellinger L and Nishiyama M: Hypoxia-inducible factor-lalpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis 24(11): 1779-1783, 2003.
21. Ollerenshaw M, Page T, Hammonds J and Demaine A : Polymorphisms in the hypoxia inducible factor-1alpha gene (HIF1A) are associated with the renal cell carcinoma phenotype. Cancer Genet Cytogenet 153(2): 122-126, 2004.
22. Chau CH, Permenter MG, Steinberg SM, Retter AS, Dahut WL, Price DK and Figg WD: Polymorphism in the hypoxia-inducible factor 1 alpha gene may confer susceptibility to androgen-independent prostate cancer. Cancer Biol Ther 4(11): 1222-1225, 2005.
23. Konac E, Onen HI, Metindir J, Alp E, Biri AA and Ekmekci A: An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers. Cancer Detect Prev 31(2): 102-109, 2007.
24. Li K, Zhang Y, Dan Z, Wang Y and Ren ZC: Association of the Hypoxia inducible factor-lalpha gene polymorphisms with gastric cancer in Tibetans. Biochem Genet 47(9-10): 625-634, 2009.
25. Fransén K, Fenech M, Fredrikson M, Dabrosin C and Söderkvist P: Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients. Mol Carcinog 45(11): 833-840, 2006.
26. Carrero P, Okamoto K, Coumailleau P, O'Brien S, Tanaka H and Poellinger L: Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol Cell Biol 20(1): 402-415, 2000.
27. Kuwai T, Kitadai Y, Tanaka S, Kuroda T, Ochiumi T, Matsumura S, Oue N, Yasui W, Kaneyasu M, Tanimoto K, Nishiyama M and Chayama K: Single nucleotide polymorphism in the hypoxia-inducible factor-lalpha gene in colorectal carcinoma. Oncol Rep 12(5): 1033-1037, 2004.
28. Ling TS, Shi RH, Zhang GX, Zhu H, Yu LZ and Ding XF: Common single nucleotide polymorphism of hypoxia-inducible factor-lalpha and its impact on the clinicopathological features of esophageal squamous cell carcinoma. Chin J Dig Dis 6(4): 155-158, 2005.
29. Li H, Bubley GJ, Balk SP, Gaziano JM, Pollak M, Stampfer MJ and Ma J: Hypoxia-inducible factor-lalpha (HIF-1alpha) gene polymorphisms, circulating insulin-like growth factor binding protein (IGFBP)-3 levels and prostate cancer. Prostate 67(12): 1354-1361, 2007.
30. Apaydin I, Konac E, Onen HI, Akbaba M, Tekin E and Ekmekci A: Single nucleotide polymorphisms in the hypoxia-inducible factor-1alpha (HIF-1alpha) gene in human sporadic breast cancer. Arch Med Res 39(3): 338-345, 2008.
31. Nadaoka J, Horikawa Y, Saito M, Kumazawa T, Inoue T, Narita S, Yuasa T, Satoh S, Nishiyama H, Ogawa O, Tsuchiya N and Habuchi T: Prognostic significance of HIF-1 alpha polymorphisms in transitional cell carcinoma of the bladder. Int J Cancer 122(6): 1297-1302, 2008.
32. Muñoz-Guerra MF, Fernández-Contreras ME, Moreno AL, Martín ID, Herráez B and Gamallo C: Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer. Ann Surg Oncol 16(8): 2351-2358, 2009.